$6.00
Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abeona’s (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement Milestone
Overview
52-week range
$4.00
$7.65
55% of range
Avg surprise (last 3)
+193.0%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
37%
EM ±5.8% · $6 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.35 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.30 | $-0.33 | +9.1% | -25.0% | +0.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.10 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $1.71 | $-0.39 | +538.5% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.24 | $-0.35 | +31.4% | — | +7.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.63 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.26 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.16 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.48 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.92 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.54 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | $9M | — | — | $400,000 | — | — | — |
| Cost of revenue | $4M | $3M | — | $488,000 | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-14M | $-23M | — | $-24M | $-23M | $-20M | — | $-15M |
| Net income | $-20M | $-17M | — | $-5M | $109M | $-12M | — | $-30M |
| EPS (diluted) | $-0.35 | $-0.30 | — | $-0.10 | $1.71 | $-0.24 | — | $-0.63 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $56M | $61M | $78M | $83M | $164M | $16M | $23M | $16M |
| Inventory | $6M | $6M | $5M | $5M | $3M | — | — | — |
| Total current assets | $165M | $183M | $205M | $216M | $232M | $88M | $101M | $113M |
| Total assets | $180M | $198M | $220M | $231M | $246M | $99M | $109M | $121M |
| Long-term debt | $2M | $5M | $8M | $11M | $14M | $11M | $13M | $14M |
| Total liabilities | $51M | $54M | $60M | $60M | $83M | $58M | $65M | $75M |
| Total equity | $128M | $145M | $159M | $171M | $164M | $41M | $44M | $46M |